4
Changes in Ownership
Ensysce Biosciences, Inc. Filed Acc 0001144204-17-062472
Chief Executive Officer disposed of 359,869 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Silvers Daniel B. Chief Executive Officer | 2017-12-05 | Other disposition | −359,869 | 1,300,202 | I |
Loading xslF345X03/tv480824_4.xml…